FIELD: chemistry.
SUBSTANCE: invention relates to organic chemistry and specifically to a method of producing 9-[2-(4-isopropylphenoxy)ethyl]adenine, which involves alkylating a trimethylsilyl adenine derivative with 1-bromo-2-(4-isopropylphenoxy)ethane, characterized by that the alkylation reaction is carried out in the presence of tri(2-trimethylsilyloxyethyl)amine without a solvent at high temperature.
EFFECT: technical result is a novel method of producing 9-[2-(4-isopropylphenoxy)ethyl]adenine, characterized by high output of the desired compound.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF PURINE ELICITING ANTIVIRAL ACTIVITY | 2003 |
|
RU2233842C1 |
9-[2-(4-ISOPROPYLPHENOXY)ETHYL]ADENINE POSSESSING ANTIDEPRESSANT AND STRESS-RELIEVING ACTION | 2013 |
|
RU2529817C1 |
ANTIDEPRESSANT FOR CORRECTION OF SIDE EFFECTS FROM NEUROLEPTICS | 2019 |
|
RU2746012C2 |
METHOD FOR PRODUCING MONOSUBSTITUTED DERIVATIVES OF URACIL | 2017 |
|
RU2648998C1 |
METHOD FOR PREPARING PHOSPHONOFORMIC ACID TRISODIUM SALT HEXAHYDRATE | 2002 |
|
RU2228336C1 |
METHOD OF PRODUCING 1-S-TRIMETHYLSILYL-2-(N,N-DIETHYLAMINO)ETHANE | 2014 |
|
RU2552527C1 |
1,3-DIHYDROBENZIMIDAZOL-2-YLIDEN AMINES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION | 2006 |
|
RU2410382C2 |
DERIVATIVES OF 4-QUINOLINYL SHOWING ANTI-HELICOBACTERIAL ACTIVITY, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEIR AND METHOD OF ITS PREPARING | 1993 |
|
RU2130933C1 |
PHARMACEUTICAL SALTS OF AMINOBICYCLO[2,2,1]HEPTANE AS NF-KB TRANSCRIPTION FACTOR INHIBITORS WITH ANTIVIRAL ACTIVITY (VERSIONS) AND USING THEM | 2009 |
|
RU2448692C2 |
METHOD OF OBTAINING GLUTEI ACID DERIVATIVE AND PYROGLUTAMIC ACID DERIVATIVE AND NOVEL INTERMEDIATE COMPOUND FOR OBTAINING SAID DERIVATIVES | 2003 |
|
RU2342360C2 |
Authors
Dates
2020-02-21—Published
2019-05-13—Filed